Similar articles for PMID: 19448844

Year	Number of Results
2006	6
2007	14
2008	13
2009	13
2010	9
2011	5
2012	7
2013	2
2014	4
2015	2
2016	3
2020	1
2024	0

1

Treatment of comorbid tobacco use in people with serious mental illness.

Lising-Enriquez K, George TP. Lising-Enriquez K, et al. J Psychiatry Neurosci. 2009 May;34(3):E1-2. J Psychiatry Neurosci. 2009. PMID: 19448844 Free PMC article. No abstract available.

2

Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?

Doggrell SA. Doggrell SA. Expert Opin Pharmacother. 2007 Dec;8(17):2903-15. doi: 10.1517/14656566.8.17.2903. Expert Opin Pharmacother. 2007. PMID: 18001252 Review.

3

Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".

Simon JA. Simon JA. Arch Intern Med. 2011 Apr 25;171(8):777-8. doi: 10.1001/archinternmed.2011.137. Arch Intern Med. 2011. PMID: 21518947 No abstract available.

4

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T. Cahill K, et al. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. Cochrane Database Syst Rev. 2012. PMID: 22513936 Updated. Review.

5

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S. Annemans L, et al. Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000. Clin Drug Investig. 2009. PMID: 19715382

6

Varenicline for smoking cessation: definite promise, but no panacea.

Klesges RC, Johnson KC, Somes G. Klesges RC, et al. JAMA. 2006 Jul 5;296(1):94-5. doi: 10.1001/jama.296.1.94. JAMA. 2006. PMID: 16820552 No abstract available.

7

Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.

Tonstad S. Tonstad S. J Cardiovasc Nurs. 2006 Nov-Dec;21(6):433-6. doi: 10.1097/00005082-200611000-00004. J Cardiovasc Nurs. 2006. PMID: 17293731 Clinical Trial.

8

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T. Cahill K, et al. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Cochrane Database Syst Rev. 2011. PMID: 21328282 Updated. Review.

9

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T. Cahill K, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Cochrane Database Syst Rev. 2010. PMID: 21154363 Updated. Review.

10

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group. Jorenby DE, et al. JAMA. 2006 Jul 5;296(1):56-63. doi: 10.1001/jama.296.1.56. JAMA. 2006. PMID: 16820547 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

77 results

Results by year